Smarter Packaging for Medical Cannabis
SmartLinks™ turns every prescription cannabis pack into a patient-only portal — digital PIL, batch and strain COA, dosing titration, Yellow Card reporting and clinic-mediated refill, without any consumer marketing layer.
Connected Packaging Features for Medical Cannabis
Everything You Need, Built In — Discover how SmartLinks™ technology enhances every aspect of your products
Digital Patient Information Leaflet
Deliver the electronic PIL for the exact product and batch in the patient's hand — multilingual, accessibility-ready, and always the current version.
Batch & Strain COA
Publish GMP batch records — cannabinoid profile, terpene profile, contaminant panel, ISO-accredited lab and date — for the specific batch dispensed.
Dosing Titration Guidance
Clinic-authored dosing and titration guidance surfaced per product, with clear driving, storage and interaction warnings — authored with prescribers, not marketed to consumers.
Yellow Card ADR Reporting
One-tap route to the [MHRA Yellow Card](https://yellowcard.mhra.gov.uk/) scheme for suspected adverse reactions, prefilled with the batch and product identifiers.
Clinic-Mediated Refill Request
Route refill requests back to the patient's prescribing clinic — never a consumer checkout — with prescription verification built in.
Tamper-Evidence & Serial Auth
Serial-level authentication proves the pack is genuine and untampered; scan history feeds anti-diversion and recall intelligence.
Patient Engagement & Adherence for Prescription Cannabis
Patient Engagement & Adherence — Not Consumer Marketing
Medical cannabis is a prescription-only medicine. UK advertising to the public is prohibited under the [Human Medicines Regulations 2012](https://www.legislation.gov.uk/uksi/2012/1916/contents) and the [MHRA Blue Guide](https://www.gov.uk/government/publications/blue-guide-advertising-and-promoting-medicines); the EU equivalent is Directive 2001/83/EC Title VIII. SmartLinks™ deliberately replaces consumer loyalty and discount mechanics with clinic-authorised patient-support tools.
Adherence Diary
Private, patient-owned log of doses, timing and effects that the patient can choose to share with their prescribing clinician — supporting titration and outcome reviews.
Clinic-Mediated Refill
Refill requests are routed to the patient's clinic, never to a consumer checkout. No cross-sell, no discount code, no loyalty points — by design.
Prescriber-Authored Education
Educational content on safe use, storage, driving and interactions, authored with the prescribing clinic — patient-support material, not brand advertising.
Verified Outcome Feedback
Structured post-dose feedback shared back to the prescriber rather than public reviews — closing the loop on titration without breaching POM advertising rules.
How It Works
Get started in minutes — no complex integration required
Serialise Every GMP Batch
Add a GS1 Digital Link QR code with unique serial identifiers per pack — aligned with GMP batch records, cold-chain data and specials-route requirements.
Patient Scans Post-Dispense
After the pack is dispensed, a scan opens the patient-only portal — PIL, batch COA, dosing, ADR reporting and clinic refill — with prescription verification recommended before commerce actions.
Support Adherence, Safety & Recall
Batch and serial data power adherence support, adverse-event capture, tamper-evidence and rapid recall — a full patient-safety loop attached to every unit.
Industry Use Cases
Medical cannabis connected packaging — common questions
Can you advertise medical cannabis to the public through a QR portal?+
No. Cannabis-based products for medicinal use (CBPMs) are prescription-only medicines under the UK's specials route, and advertising POMs to the general public is prohibited by regulation 279 of the Human Medicines Regulations 2012 and the MHRA Blue Guide. The equivalent EU rule is Article 88 of Directive 2001/83/EC. SmartLinks builds the portal as patient-only content — PIL, batch, dosing, safety, refill — never as consumer marketing.
Why is there no loyalty, discount or cross-sell layer?+
Consumer-style engagement — points, referral bounties, discount codes, cross-sell — is inappropriate for a scheduled POM and can be treated as unlawful promotion or inducement. The medical cannabis flow deliberately replaces those mechanics with clinic-mediated refill, adherence diary and prescriber-authored education. The CBD page is where consumer mechanics live for the non-POM cannabinoid range.
Is a digital PIL actually allowed?+
Yes. The MHRA best-practice guidance on patient information leaflets supports digital PIL alongside paper, and the EMA electronic product information (ePI) framework is heading the same way for centrally-authorised products. SmartLinks routes the digital PIL for the exact batch and product a patient scans.
How is adverse-event reporting handled?+
The portal offers a one-tap route to the MHRA Yellow Card scheme, prefilled with the product name, batch and serial from the scan — reducing friction for patients and prescribers reporting suspected adverse reactions.
How does refill work without a consumer checkout?+
Refill requests are routed to the patient's prescribing clinic (not a shop cart), with prescription and identity verification before any dispensing conversation. The pack triggers the request; the clinic remains the authoriser — keeping the flow inside the specials-route and prescriber-of-record framework.
Ready to Give Prescription Cannabis a Patient-Only Portal?
Talk to us about deploying SmartLinks™ across your CBPM range — digital PIL, batch COA, Yellow Card reporting and clinic-mediated refill, without any consumer marketing layer.